Search Results - "Etter, Tobias J"

104-LB: Interim Analysis of a Prospective Study Investigating User Satisfaction and Metabolic Outcome of People with T1D Using an Innovative Modular Micropump System by DAIN, ALEJANDRO, MOCERI, SANDRA, DAGENBACH, NICOLE, REES, CHRISTEN, VULCANO, CRISTINA, VOGT, GERHARD, ETTER, TOBIAS J.

“…Aims: People with type 1 diabetes (T1D) can administer insulin by multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII). Despite…”
Get full text

95-LB: Interim Data from a Prospective Study Measuring User Satisfaction and Metabolic Outcome while Using a Novel Modular Patch Pump System by DAIN, ALEJANDRO, MOCERI, SANDRA, DAGENBACH, NICOLE, REES, CHRISTEN, VULCANO, CRISTINA, VOGT, GERHARD, ETTER, TOBIAS J.

“…Background and aims: Intensified insulin therapy for type 1 diabetes (T1D) can be administered by multiple daily injection therapy (MDI) or continuous…”
Get full text

894-P: The Risk for Type 2 Diabetes beyond Age: Contributors to the FINDRISC-Score in Each Age Category by EHRMANN, DOMINIC, ETTER, TOBIAS J., WEISSMANN, JOERG, KULZER, BERNHARD, HERMANNS, NORBERT

“…With increasing age, the risk for type 2 diabetes increases. Little is known about the relative importance of other risk factors for different age groups…”
Get full text

1898-LB: Interim Analysis of a Study Investigating User Satisfaction and Metabolic Outcome of PwT1D Using an Innovative Micropump by Dain, Alejandro, Scheibner, Katharina, Moceri, Sandra, Dagenbach, Nicole, Vulcano, Cristina, Vogt, Gerhard, Best, Julia, Etter, Tobias J

“…Aims: People with type 1 diabetes (PwT1D) use either multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII), but CSII adoption is…”
Get full text